Therapeutic potential of bone marrow-derived mesenchymal stem cells on experimental liver fibrosis

M T Abdel Aziz1, H M Atta, S Mahfouz

  • 1Department of Medical Biochemistry, Unit of Biochemistry and Molecular Biology, Faculty of Medicine, Cairo University, Cairo, Eqypt. talaatbdaziz@yahoo.co.uk

Abstract

Insights

Mesenchymal stem cells (MSC) show significant therapeutic potential against liver fibrosis in rats. MSC treatment reduced collagen deposition and improved liver function, indicating a promising antifibrotic effect.

Area of Science:

  • Stem cell research
  • Hepatology
  • Fibrosis research

Background:

  • Liver fibrosis is a chronic condition characterized by excessive collagen deposition.
  • Mesenchymal stem cells (MSC) are being investigated for their regenerative and immunomodulatory properties.

Purpose of the Study:

  • To evaluate the therapeutic efficacy of MSC in an experimental model of liver fibrosis in rats.
  • To assess the impact of MSC on collagen deposition, liver function markers, and potential differentiation into hepatocytes.

Main Methods:

  • Mesenchymal stem cells (MSC) were isolated from rat bone marrow and characterized.
  • Liver fibrosis was induced in female rats using CCl4 injection.
  • Rats received tail vein infusions of MSC, and various parameters including histopathology, liver function tests (ALT, albumin), hydroxyproline content, and gene expression (collagen, sry) were analyzed.

Main Results:

  • MSC treatment significantly reduced liver collagen gene expression and hydroxyproline content in fibrotic rats (p<0.001).
  • A significant improvement in serum albumin levels was observed in the MSC-treated group (p<0.05).
  • The Y-chromosome gene (sry) was detected in the liver of female rats treated with male MSC, suggesting cell engraftment.

Conclusions:

  • Mesenchymal stem cells (MSC) demonstrate a significant antifibrotic effect in experimental liver fibrosis.
  • MSC therapy can minimize collagen deposition and potentially differentiate into hepatocytes, offering therapeutic benefits.
  • MSC represent a promising therapeutic strategy for managing liver fibrosis.

Related Concept Videos

Mesenchymal Stem Cells01:19

Mesenchymal Stem Cells

Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their access...
Stem Cell Therapy for Tissue Regeneration01:21

Stem Cell Therapy for Tissue Regeneration

Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...
Liver Regeneration01:24

Liver Regeneration

The liver is an important organ in vertebrates that plays an essential role in metabolism. It is also responsible for storing and redistributing nutrients such as carbohydrates, fats, and vitamins in the body. Additionally, the liver releases bile salts which are critical for digesting food and eliminating toxic metabolites from the body.
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are large...